{"success":true,"data":{"pressRelease":{"id":"137551","rtpr_id":"nPn5l5dZZa-20260908","ticker":"WDH","exchange":"NYSE","all_tickers":["WDH","717Y"],"title":"Waterdrop Inc. Reports Second Quarter 2026 Unaudited Financial Results","author":"PR Newswire","published_at":"2026-09-08T11:09:00.232Z","article_body":"Waterdrop Inc. Reports Second Quarter 2026 Unaudited Financial Results\n\nPR Newswire\n\nBEIJING, Sept. 8, 2026\n\nBEIJING, Sept. 8, 2026 /PRNewswire/ -- On September 8, Waterdrop Inc. (NYSE:\nWDH) released its unaudited financial results for the second quarter ended\nJune 30, 2026. In Q2 2026, the company's operating revenue reached RMB1,448.2\nmillion, up 72.8% year-over-year; net profit attributable to ordinary\nshareholders was RMB125.8 million, marking 18 consecutive quarters of\nprofitability. As of August 31, 2026, the company had cumulatively repurchased\napproximately 62.9 million ADSs (American Depositary Shares) from the open\nmarket.\n\nWith solid performance in Q2, the company achieved rapid revenue growth. Going\nforward, Waterdrop will continue to increase investment in AI technology\ninnovation, making healthcare and financial services more accessible to the\npublic.\n\nInsurance Business Grows Steadily, AI Penetration Continues to Rise\n\nThis quarter, the insurance business maintained strong growth, with\ninsurance-related revenue up 80.5% year-over-year. Meanwhile, profitability\ncontinued to improve, with insurance business operating profit reaching\nRMB183.6 million, up 20% quarter-over-quarter. Waterdrop is comprehensively\naccelerating the application of AI technology across the entire insurance\nvalue chain. Premiums facilitated by 'AI Medical Insurance Expert' rose by\n25.6% quarter-over-quarter. First-year premiums for long-term insurance grew\n33.4% quarter-over-quarter.\n\nIn terms of product innovation, leveraging its massive claims data and user\nprofile analytics, Waterdrop has broken the traditional static logic of\nblanket rejection for people with chronic diseases, removing barriers to\ncoverage for users with pre-existing conditions one by one. This quarter,\nWaterdrop launched 'Rongyibao,' the market's first long-term critical illness\ninsurance product that requires no health disclosure and offers five-year\nguaranteed renewability, covering more than 100 critical illnesses with\noptional riders for accidental death and disability benefits. At the same\ntime, the company expanded 'Jixing Gaozhao' series with the market's first\nlifetime specified disease insurance product requiring no health disclosure.\n\nWaterdrop Medical Crowdfunding: 499 Million Users Have Donated RMB74.7 Billion\nto 3.82 Million Patients\n\nThis quarter, Waterdrop Medical Crowdfunding continued to fulfill its role in\nproviding emergency relief. Since its launch in 2016, approximately 499\nmillion donors have cumulatively contributed RMB74.7 billion to 3.82 million\npatients with critical illnesses through Waterdrop Medical Crowdfunding.\n\nWaterdrop Medical Crowdfunding has always practiced the philosophy of \"tech\nfor good,\" building a dual safeguard system for case authenticity verification\nand transparent fund flow through AI technology. This quarter, Waterdrop\nMedical Crowdfunding introduced AI in risk management: relying on the semantic\nparsing capabilities of large models combined with strategic analysis, it\nbuilt an intelligent identification matrix for multiple high-risk scenarios,\nprecisely detecting dimensions such as fundraiser sensitive-identity\nrecognition and abnormal assets. This has significantly improved the accuracy\nand efficiency of platform risk identification, ensuring the authenticity and\nreliability of fundraising cases.\n\nIn addition, Waterdrop Medical Crowdfunding has launched AI fundraising\nassistants in 548 cities nationwide. Leveraging intelligent, round-the-clock\nservice, the assistants provide professional support to fundraising users\nacross the country — especially those in remote areas and those unfamiliar\nwith internet operations. Services cover end-to-end fundraising Q&A, basic\ncritical-illness health education, and efficient fundraising guidance, making\ncritical illness relief more precise and convenient and filling gaps left by\nhuman service coverage.\n\nE-Find Platform: Q2 Revenue RMB35.2 Million, Partners with 255 Pharma\nCompanies and CROs\n\nWaterdrop's digital clinical trial solutions business grew steadily, with\nE-Find Platform's net revenue reaching RMB35.2 million, up 26.8%\nyear-over-year. This quarter, E-Find Platform established partnerships with\n255 well-known domestic and overseas pharma companies and CROs. As of June 30,\n2026, it had cumulatively delivered 1,873 clinical trial projects with 17,052\nenrolled patients.\n\nIn terms of social responsibility, in response to severe rainstorms and floods\nacross multiple areas of Guangxi and debris-flow disasters at the Jilong Port\nin Jilong County, Shigatse, Tibet, Waterdrop urgently established a disaster\nrelief emergency response team and quickly launched rescue operations.\nWaterdrop Charity immediately launched a \"Relief\" special section on its\nhomepage and, in collaboration with multiple foundations, rushed aid to\naffected areas — delivering over 2,000 relief supply packages to the Guangxi\ndisaster zone and doing its utmost to help affected communities through the\ncrisis.\n\nShen Peng, Founder and CEO of Waterdrop Inc., said: \"Waterdrop has always\nregarded technology as our core driver. With AI embedded across our platforms,\nwe are well positioned to capture the growing demand in our existing\nbusinesses. In the future, we remain committed to delivering greater value for\nour shareholders in the years to come.\"\n\nView original\ncontent:https://www.prnewswire.com/news-releases/waterdrop-inc-reports-second-quarter-2026-unaudited-financial-results-302872182.html\n(https://www.prnewswire.com/news-releases/waterdrop-inc-reports-second-quarter-2026-unaudited-financial-results-302872182.html)\n\nSOURCE Waterdrop Inc.\n\n\n\nHou Bin, houbin11@shuidi-inc.com, +86-18911997242\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nPn5l5dZZa-20260908","title":"Waterdrop Inc. Reports Second Quarter 2026 Unaudited Financial Results","author":"PR Newswire","ticker":"WDH","created":"2026-09-08T11:09:00.232Z","tickers":["WDH","717Y"],"exchange":"NYSE","article_body":"Waterdrop Inc. Reports Second Quarter 2026 Unaudited Financial Results\n\nPR Newswire\n\nBEIJING, Sept. 8, 2026\n\nBEIJING, Sept. 8, 2026 /PRNewswire/ -- On September 8, Waterdrop Inc. (NYSE:\nWDH) released its unaudited financial results for the second quarter ended\nJune 30, 2026. In Q2 2026, the company's operating revenue reached RMB1,448.2\nmillion, up 72.8% year-over-year; net profit attributable to ordinary\nshareholders was RMB125.8 million, marking 18 consecutive quarters of\nprofitability. As of August 31, 2026, the company had cumulatively repurchased\napproximately 62.9 million ADSs (American Depositary Shares) from the open\nmarket.\n\nWith solid performance in Q2, the company achieved rapid revenue growth. Going\nforward, Waterdrop will continue to increase investment in AI technology\ninnovation, making healthcare and financial services more accessible to the\npublic.\n\nInsurance Business Grows Steadily, AI Penetration Continues to Rise\n\nThis quarter, the insurance business maintained strong growth, with\ninsurance-related revenue up 80.5% year-over-year. Meanwhile, profitability\ncontinued to improve, with insurance business operating profit reaching\nRMB183.6 million, up 20% quarter-over-quarter. Waterdrop is comprehensively\naccelerating the application of AI technology across the entire insurance\nvalue chain. Premiums facilitated by 'AI Medical Insurance Expert' rose by\n25.6% quarter-over-quarter. First-year premiums for long-term insurance grew\n33.4% quarter-over-quarter.\n\nIn terms of product innovation, leveraging its massive claims data and user\nprofile analytics, Waterdrop has broken the traditional static logic of\nblanket rejection for people with chronic diseases, removing barriers to\ncoverage for users with pre-existing conditions one by one. This quarter,\nWaterdrop launched 'Rongyibao,' the market's first long-term critical illness\ninsurance product that requires no health disclosure and offers five-year\nguaranteed renewability, covering more than 100 critical illnesses with\noptional riders for accidental death and disability benefits. At the same\ntime, the company expanded 'Jixing Gaozhao' series with the market's first\nlifetime specified disease insurance product requiring no health disclosure.\n\nWaterdrop Medical Crowdfunding: 499 Million Users Have Donated RMB74.7 Billion\nto 3.82 Million Patients\n\nThis quarter, Waterdrop Medical Crowdfunding continued to fulfill its role in\nproviding emergency relief. Since its launch in 2016, approximately 499\nmillion donors have cumulatively contributed RMB74.7 billion to 3.82 million\npatients with critical illnesses through Waterdrop Medical Crowdfunding.\n\nWaterdrop Medical Crowdfunding has always practiced the philosophy of \"tech\nfor good,\" building a dual safeguard system for case authenticity verification\nand transparent fund flow through AI technology. This quarter, Waterdrop\nMedical Crowdfunding introduced AI in risk management: relying on the semantic\nparsing capabilities of large models combined with strategic analysis, it\nbuilt an intelligent identification matrix for multiple high-risk scenarios,\nprecisely detecting dimensions such as fundraiser sensitive-identity\nrecognition and abnormal assets. This has significantly improved the accuracy\nand efficiency of platform risk identification, ensuring the authenticity and\nreliability of fundraising cases.\n\nIn addition, Waterdrop Medical Crowdfunding has launched AI fundraising\nassistants in 548 cities nationwide. Leveraging intelligent, round-the-clock\nservice, the assistants provide professional support to fundraising users\nacross the country — especially those in remote areas and those unfamiliar\nwith internet operations. Services cover end-to-end fundraising Q&A, basic\ncritical-illness health education, and efficient fundraising guidance, making\ncritical illness relief more precise and convenient and filling gaps left by\nhuman service coverage.\n\nE-Find Platform: Q2 Revenue RMB35.2 Million, Partners with 255 Pharma\nCompanies and CROs\n\nWaterdrop's digital clinical trial solutions business grew steadily, with\nE-Find Platform's net revenue reaching RMB35.2 million, up 26.8%\nyear-over-year. This quarter, E-Find Platform established partnerships with\n255 well-known domestic and overseas pharma companies and CROs. As of June 30,\n2026, it had cumulatively delivered 1,873 clinical trial projects with 17,052\nenrolled patients.\n\nIn terms of social responsibility, in response to severe rainstorms and floods\nacross multiple areas of Guangxi and debris-flow disasters at the Jilong Port\nin Jilong County, Shigatse, Tibet, Waterdrop urgently established a disaster\nrelief emergency response team and quickly launched rescue operations.\nWaterdrop Charity immediately launched a \"Relief\" special section on its\nhomepage and, in collaboration with multiple foundations, rushed aid to\naffected areas — delivering over 2,000 relief supply packages to the Guangxi\ndisaster zone and doing its utmost to help affected communities through the\ncrisis.\n\nShen Peng, Founder and CEO of Waterdrop Inc., said: \"Waterdrop has always\nregarded technology as our core driver. With AI embedded across our platforms,\nwe are well positioned to capture the growing demand in our existing\nbusinesses. In the future, we remain committed to delivering greater value for\nour shareholders in the years to come.\"\n\nView original\ncontent:https://www.prnewswire.com/news-releases/waterdrop-inc-reports-second-quarter-2026-unaudited-financial-results-302872182.html\n(https://www.prnewswire.com/news-releases/waterdrop-inc-reports-second-quarter-2026-unaudited-financial-results-302872182.html)\n\nSOURCE Waterdrop Inc.\n\n\n\nHou Bin, houbin11@shuidi-inc.com, +86-18911997242\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved."},"type":"article","timestamp":"2026-09-08T11:09:00.286887495Z","server_sent_at_ms":1788865740286},"received_at":"2026-09-08T11:09:00.344Z","source_url":"https://www.prnewswire.com/news-releases/waterdrop-inc-reports-second-quarter-2026-unaudited-financial-results-302872182.html"},"analysis":{"id":"126426","press_release_id":"137551","analysis_json":{"industry":{"label":"Insurance Brokers","sector":"Financials"},"redFlags":[],"eventType":"earnings","narrative":"Waterdrop reported Q2 2026 operating revenue of RMB1,448.2 million, up 72.8% year-over-year, with net profit attributable to ordinary shareholders of RMB125.8 million marking its 18th consecutive profitable quarter.\n\nThe insurance business drove the quarter: insurance-related revenue rose 80.5% YoY and insurance operating profit reached RMB183.6 million, up 20% quarter-over-quarter. The company also launched Rongyibao, billed as the market's first long-term critical illness product requiring no health disclosure, and expanded the Jixing Gaozhao series.\n\nThe E-Find clinical trial platform posted RMB35.2 million in net revenue, up 26.8% YoY, and now partners with 255 pharma companies and CROs after delivering 1,873 cumulative trial projects. Management said it will keep increasing AI investment to make healthcare and financial services more accessible.","sentiment":"bullish","agentHooks":{"shouldPost":true,"suggestedAngle":"72.8% revenue growth and 18 straight profitable quarters put Waterdrop's AI-led insurtech momentum on display alongside ongoing ADS buybacks."},"keyFigures":{"revenue":"RMB1,448.2 million","revenueYoy":"72.8%","customDimensions":{"efind_partners":255,"efind_revenue_yoy":"26.8%","long_term_fyp_qoq":"33.4%","insurance_revenue_yoy":"80.5%","ai_expert_premiums_qoq":"25.6%","efind_platform_revenue":"RMB35.2 million","ads_repurchased_cumulative":"approximately 62.9 million","insurance_operating_profit":"RMB183.6 million","crowdfunding_cumulative_donors":"499 million","insurance_operating_profit_qoq":"20%","consecutive_profitable_quarters":18,"crowdfunding_cumulative_patients":"3.82 million","crowdfunding_cumulative_donations":"RMB74.7 billion","net_profit_attributable_shareholders":"RMB125.8 million"}},"quotedText":"With AI embedded across our platforms, we are well positioned to capture the growing demand in our existing businesses.","namedEntities":{"people":[{"name":"Shen Peng","role":"Founder and CEO"},{"name":"Hou Bin","role":"media contact"}],"products":["Waterdrop Medical Crowdfunding","E-Find Platform","AI Medical Insurance Expert","Rongyibao","Jixing Gaozhao","Waterdrop Charity"],"companies":[{"name":"Waterdrop Inc.","ticker":"WDH","relationship":"filer"}],"dollarAmounts":[{"amount":"RMB1,448.2 million","context":"Q2 2026 operating revenue"},{"amount":"RMB125.8 million","context":"net profit attributable to ordinary shareholders"},{"amount":"RMB183.6 million","context":"insurance business operating profit"},{"amount":"RMB35.2 million","context":"E-Find Platform Q2 net revenue"},{"amount":"RMB74.7 billion","context":"cumulative medical crowdfunding donations since 2016"}]},"materialImpact":{"score":4,"reasoning":"Issuer-authored quarterly results with 72.8% YoY revenue growth, an 18th consecutive profitable quarter, and accelerating insurance-segment economics. No consensus comparison is stated, so it is scored 4 rather than 5."},"tickerRelevance":{"others":[],"primary":"WDH"},"globalImportance":35,"audienceRelevance":28,"eventTypeSecondary":["buyback"],"importanceComponents":{"tickerTier":"small/mid-cap China ADR","eventGravity":"strong quarterly print: +72.8% revenue YoY, 18th consecutive profitable quarter","sectorWeight":"insurtech / insurance brokerage","issuerAuthored":true,"retailFavoriteBoost":0,"consensusComparisonAvailable":false}},"event_type":"earnings","event_type_secondary":["buyback"],"sentiment":"bullish","material_impact_score":4,"narrative":"Waterdrop reported Q2 2026 operating revenue of RMB1,448.2 million, up 72.8% year-over-year, with net profit attributable to ordinary shareholders of RMB125.8 million marking its 18th consecutive profitable quarter.\n\nThe insurance business drove the quarter: insurance-related revenue rose 80.5% YoY and insurance operating profit reached RMB183.6 million, up 20% quarter-over-quarter. The company also launched Rongyibao, billed as the market's first long-term critical illness product requiring no health disclosure, and expanded the Jixing Gaozhao series.\n\nThe E-Find clinical trial platform posted RMB35.2 million in net revenue, up 26.8% YoY, and now partners with 255 pharma companies and CROs after delivering 1,873 cumulative trial projects. Management said it will keep increasing AI investment to make healthcare and financial services more accessible.","key_figures":{"revenue":"RMB1,448.2 million","revenueYoy":"72.8%","customDimensions":{"efind_partners":255,"efind_revenue_yoy":"26.8%","long_term_fyp_qoq":"33.4%","insurance_revenue_yoy":"80.5%","ai_expert_premiums_qoq":"25.6%","efind_platform_revenue":"RMB35.2 million","ads_repurchased_cumulative":"approximately 62.9 million","insurance_operating_profit":"RMB183.6 million","crowdfunding_cumulative_donors":"499 million","insurance_operating_profit_qoq":"20%","consecutive_profitable_quarters":18,"crowdfunding_cumulative_patients":"3.82 million","crowdfunding_cumulative_donations":"RMB74.7 billion","net_profit_attributable_shareholders":"RMB125.8 million"}},"named_entities":{"people":[{"name":"Shen Peng","role":"Founder and CEO"},{"name":"Hou Bin","role":"media contact"}],"products":["Waterdrop Medical Crowdfunding","E-Find Platform","AI Medical Insurance Expert","Rongyibao","Jixing Gaozhao","Waterdrop Charity"],"companies":[{"name":"Waterdrop Inc.","ticker":"WDH","relationship":"filer"}],"dollarAmounts":[{"amount":"RMB1,448.2 million","context":"Q2 2026 operating revenue"},{"amount":"RMB125.8 million","context":"net profit attributable to ordinary shareholders"},{"amount":"RMB183.6 million","context":"insurance business operating profit"},{"amount":"RMB35.2 million","context":"E-Find Platform Q2 net revenue"},{"amount":"RMB74.7 billion","context":"cumulative medical crowdfunding donations since 2016"}]},"model_name":"glm-4.7","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-09-08T11:26:14.738Z","global_importance":35,"audience_relevance":28,"importance_components":{"tickerTier":"small/mid-cap China ADR","eventGravity":"strong quarterly print: +72.8% revenue YoY, 18th consecutive profitable quarter","sectorWeight":"insurtech / insurance brokerage","issuerAuthored":true,"retailFavoriteBoost":0,"consensusComparisonAvailable":false}},"durationMs":null,"modelName":"glm-4.7"}}